Oklahoma Proton Center

What Oklahoma Proton Center does

Oklahoma Proton Center is a private, non-profit 501(c)(3) radiation oncology facility founded in 2009 in Oklahoma City, owned by the Oklahoma Proton Foundation. It operates as one of the first proton therapy centers in the United States and the only one of five such facilities serving the Southwest region. The center's core technology is proton therapy using pencil beam scanning, which exploits the Bragg Peak phenomenon to deposit maximum radiation dose at the tumor site while eliminating exit dose to surrounding healthy tissue. Complementary modalities include TomoTherapy image-guided IMRT, brachytherapy, TULSA-PRO high-intensity focused ultrasound, and Theranostics/Pluvicto radioligand therapy, delivered under an integrated 360 Cancer Care program that also encompasses medical oncology, surgical oncology, screening, genetic testing, and survivorship services.

The business model is direct patient treatment services revenue, billed to Medicare, commercial insurers (Blue Cross, Aetna, Cigna, Humana, UHC, among others with over 70% of commercial plans covering proton therapy), and patients, with needs-based charity care available for Oklahoma residents. The center's go-to-market relies on physician referrals from urologists, oncologists, and other specialists, augmented by content marketing, patient testimonials, a podcast, community events, and telehealth-enabled consultations that draw patients from all 50 U.S. states and multiple countries. The center is APEx-accredited by the American Society for Radiation Oncology (ASTRO) and has treated 6,000+ patients since opening.

Customer segments are organized by cancer type — prostate, breast, lung, brain/CNS, head & neck, GI/esophageal/liver, and pediatric/rare cancers — with the Prostate Cancer Center of Excellence serving as a verticalized sub-brand. Leadership includes Medical Director Dr. John Chang (previously at Northwestern Memorial Hospital and Vanderbilt), President Tom Welch, and CFO Christopher Brown. A clinical collaboration with MD Anderson Cancer Center and an operational affiliation with Oklahoma Cancer Center extend the center's reach beyond a single-site specialty clinic model.

Name

Oklahoma Proton Center

Legal name

Oklahoma Proton Center, LLC

Website

https://okcproton.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Oklahoma Proton Center is a 501(c)(3) radiation oncology facility in Oklahoma City that delivers proton therapy and complementary modalities (TomoTherapy, TULSA-PRO, Theranostics) to cancer patients referred from all 50 U.S. states, with over 6,000 patients treated since 2009.

Ownership category

akta.pro rank

Product category

Radiation Oncology / Proton Therapy Cancer Treatment

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Diagnostic Imaging Centers (621512)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Proton radiation therapy
• Cancer treatment services
• Radiation oncology
• Image-guided radiotherapy
• Oncology treatment center

Headquarters

HQ city

Oklahoma City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Patient Treatment Services: Direct healthcare services revenue generated from treating cancer patients with proton therapy and related radiation treatments. Services are billed to insurance providers, Medicare, and patients directly. The center is a 501c3 not-for-profit organization.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Oklahoma Proton Center is a healthcare facility providing proton therapy as its core radiation treatment for cancer, using high-energy proton beams and pencil beam scanning to precisely target tumors while sparing surrounding healthy tissue. The center also delivers complementary radiation modalities including TomoTherapy, brachytherapy, TULSA-PRO high-intensity focused ultrasound, and theranostics/Pluvicto, alongside integrated oncology services (medical oncology, screening, genetic testing) and supportive care programs under its 360 Cancer Care umbrella.

Product overview

Oklahoma Proton Center is a healthcare facility offering proton therapy as its core technology, supported by complementary radiation modalities (TomoTherapy®, Brachytherapy, TULSA-PRO®, Theranostics/Pluvicto) and integrated cancer care services through the 360 Cancer Care program. The center provides comprehensive oncology services including radiation oncology, medical oncology, lung cancer screening, genetic cancer screening, and telehealth. Specialized programs include a Prostate Cancer Center of Excellence, clinical trials, and patient support communities (Proton Fight Club, Cancer PALS). The facility has treated over 6,000 patients since opening in 2009.

Differentiator

Problem solved

Functional benefit

Products and services

• Proton Therapy Advanced radiation treatment that uses precisely controlled high-energy proton beams to target and destroy cancer cells while sparing surrounding healthy tissue, leveraging the Bragg Peak phenomenon for maximum dose at the tumor site with no exit dose. Non-invasive, non-surgical, FDA-approved since 1988, and used to treat brain, head and neck, breast, lung, GI, liver, esophageal, and prostate cancers.
• TomoTherapy An advanced form of image-guided intensity-modulated radiation therapy (IMRT) that integrates CT imaging with spiral delivery for precise tumor targeting, used for cancer patients whose treatment plans require a complementary radiation modality to proton therapy.
• Brachytherapy Internal radiation therapy using radioactive seeds to deliver high-dose radiation to a small, localized area, primarily used for prostate and other localized cancers requiring concentrated internal dose.
• TULSA-PRO High-Intensity Focused Ultrasound (HIFU) treatment for prostate cancer using real-time MRI guidance for precise, non-invasive tissue ablation of the prostate.
• Theranostics / Pluvicto Targeted radioligand therapy for prostate cancer that combines diagnostic imaging with therapeutic radiation delivery, enabling personalized identification and treatment of prostate cancer cells.
• Lung Cancer Screening Cancer screening services including low-dose CT scans for lung cancer, as well as mammograms, colonoscopies, and PSA checks for at-risk patients.
• Genetic Cancer Screening Genetic testing and screening services used to identify hereditary cancer risk factors for patients and at-risk family members.
• Telehealth Virtual consultation and follow-up appointment services that enable remote patient care, including initial evaluations and post-treatment follow-up for patients outside the Oklahoma City area.
• 360 Cancer Care Comprehensive integrated cancer care program that bundles immunotherapy, chemotherapy, surgery, proton therapy, nutrition, physical therapy, counseling, mental health, functional medicine, and survivorship programs into a single coordinated care experience for cancer patients.
• Prostate Cancer Center of Excellence Specialized clinical program within Oklahoma Proton Center focused on prostate cancer diagnosis and treatment using proton therapy, brachytherapy, TULSA-PRO HIFU, theranostics, and SpaceOAR hydrogel spacer technology.
• Prostate Biopsy & Diagnosis Prostate biopsy and diagnostic services supporting prostate cancer detection and treatment planning for at-risk and diagnosed patients.
• Arthritis Treatment Low-dose radiation therapy treatment for arthritis, leveraging the center's radiation therapy capabilities for non-cancer musculoskeletal indications.

Quantifiable outcome

• 99% cancer free at 5.5 years for prostate cancer patients
• +16 more outcomes

Named customers11 records

Segments7 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• MD Anderson Cancer CentercoreStrategic or Co-development PartnerClinical collaboration and medical expertise sharing. Dr. Steven J. Frank from MD Anderson served as clinical expert on the award-winning documentary 'The Accelerator' about proton therapy history.
• Oklahoma Proton FoundationcoreOthersThe center is owned by the Oklahoma Proton Foundation, an independent 501c3 not-for-profit organization with a mission of funding research, education, and charitable care for cancer patients. The Foundation is governed by a board of four independent directors.
• Tinker Air Force BaseminorStrategic or Co-development PartnerCommunity engagement partnership. Pilots from Tinker Air Force Base surprised pediatric patient Corbin Patton with a challenge coin after completing treatment, supporting patient morale.
• Oklahoma Cancer CentercoreStrategic or Co-development PartnerOklahoma Cancer Center is affiliated with Oklahoma Proton Center, offering comprehensive 360 Cancer Care including immunotherapy, chemotherapy, surgery, and proton therapy. Provides integrated cancer treatment services under one umbrella.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Mayo Clinic Radiation Oncology: National destination cancer program with proton therapy capability as part of a much broader specialty offering. Overlaps with OPC on patient draw for complex cancers and serves as a benchmark for outcomes and reputation.
• MD Anderson Cancer Center Proton Therapy Center: The largest U.S. cancer center and a strategic partner of OPC. Competes for complex, high-acuity patients with a vastly broader portfolio (surgery, systemic therapy, multi-modality radiation) and clinical-trial depth.

Direct peers

• Provision CARES Proton Therapy Center: Freestanding proton center in Knoxville, TN treating a similar mix of prostate, breast, lung, and head & neck cancers. Comparable freestanding operating model, payer mix, and patient-acquisition motion via physician referrals and self-pay travel patients.
• Seattle Cancer Care Alliance Proton Therapy: Northwest proton therapy program with a comparable focus on complex and pediatric cases. Direct peer on clinical offering, payer mix, and regional referral dynamics.
• ProCure Proton Therapy Centers: Multi-site proton therapy operator (historically NJ, IL, OK, WA) that scaled a freestanding proton model nationally. Most directly comparable on operating model and capital-intensive growth playbook.
• California Protons Cancer Therapy Center: Freestanding proton therapy center in San Diego offering the same single-modality proton focus as OPC, with a multi-modality care model and direct patient-pay/referral GTM. Closest structural comp to a non-hospital proton operator.
• University of Florida Health Proton Therapy Institute: High-volume proton center in Jacksonville treating thousands of patients across prostate, breast, lung, pediatric, and head & neck cancers. Comparable scale, patient mix, and clinical-trial orientation.
• Loma Linda University Medical Center Proton Treatment and Research Center: First hospital-based proton therapy center in the U.S., treating a similar broad cancer mix including pediatric cases. Comparable patient demographic and clinical positioning, with academic-medical-center differences.
• Northwestern Medicine Chicago Proton Center: Academic proton center within Northwestern Medicine, treating a similar multi-tumor-type case mix. Direct clinical peer with overlapping physician-network connections (the OPC Medical Director previously held leadership roles at Northwestern).
• Emory Proton Therapy Center (Winship Cancer Institute): Southeast-based academic proton center with a comparable multi-tumor-type offering and a similarly large geographic catchment. Direct clinical competitor for patients traveling from surrounding states.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/okprotoncenter
• YouTubeyoutube.com/channel/UCO-3bzzZ0nPdRNAs4_-cfkw
• Facebookfacebook.com/OKProtonCenter
• Instagraminstagram.com/okprotoncenter
• LinkedInlinkedin.com/company/oklahoma-proton-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oklahoma Proton Center